Alicia Uceda-Heras

Mrs. Alicia Uceda-Heras


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
DODiana Ortega‐Cruz
Diana Ortega‐Cruz
AUAlicia Uceda-Heras
Alicia Uceda-Heras
JIJuan Eugenio Iglesias
Juan Eugenio Iglesias
MZMaría Ascensión Zea‐Sevilla
María Ascensión Zea‐Sevilla
BSBryan Strange
Bryan Strange
Alberto RábanoAlberto Rábano
Alberto Rábano
Introduction: Hippocampal sclerosis of aging (HS) is defined by end‐stage histological findings, strongly associated with limbic‐predominant age‐related TAR DNA‐binding protein 43 (TDP‐43) encephalopathy (LATE). We aimed to characterize features of early HS to refine the understanding of its role within combined pathology.Methods: We studied 159 brain donations from the multimodal Vallecas Alzheimer's Center Study. A staging system (0 to IV) was developed to account for HS progression and analyzed in relation to pre‐mortem cognitive and magnetic resonance imaging (MRI) data.Results: Our HS staging system displayed a significant correlation with disease duration, cognitive performance, and combined neuropathologies, especially with LATE. Two‐level assessment along the hippocampal longitudinal axis revealed an anterior‐posterior gradient of HS severity. In vivo MRI showed focally reduced hippocampal gray matter density as a function of HS staging.Discussion: The association of this staging system with clinical progression and structural differences supports its utility in the characterization and potential in vivo monitoring of HS.Highlights: The definition of hippocampal sclerosis of aging (HS) is currently limited to an end‐stage pathological fingerprint. We characterize early HS histological features to define a complete staging system. The proposed staging displays a parallel but not identical progression to limbic‐predominant age‐related TAR DNA‐binding protein 43 (TDP‐43) encephalopathy (LATE). The proposed staging also reflects the expected demographic and cognitive differences associated with HS. In vivo magnetic resonance imaging (MRI) showed focal hippocampal gray matter loss as a function of HS staging.

10 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IGIván Burgueño García
Iván Burgueño García
MMMaría José López Martínez
María José López Martínez
AUAlicia Uceda-Heras
Alicia Uceda-Heras
LGLucía García-Carracedo
Lucía García-Carracedo
MZMaría Ascensión Zea-Sevilla
María Ascensión Zea-Sevilla
Alberto RábanoAlberto Rábano
Alberto Rábano
Background/Objectives: Clinicopathological research in late-life dementia has focused recently on combined neurodegenerative and vascular conditions underlying the high phenotypic heterogeneity of patients. The Vallecas Alzheimer’s Reina Sofía (VARS) cohort (n > 550), and particularly the series of associated brain donations (VARSpath cohort) are presented here. The aim of this study is to contribute to research in dementia with a well-characterized cohort from a single center. Methods: A total of 167 patients with complete neuropathological work-ups were analyzed here. The cohort is characterized by a high female predominance (79%), advanced age at death (88 yrs.), and a high frequency of ApoE-e4 haplotype (43%). Results: The main neuropathological diagnosis was Alzheimer’s disease (79.6%), followed by vascular dementia (10.2%) and Lewy body dementia (6%). Overall, intermediate-to-high cerebrovascular disease was observed in 38.9%, Lewy body pathology in 57.5%, LATE (TDP-43 pathology) in 70.7%, ARTAG in 53%, and argyrophilic grain disease in 12% of the patients. More than one pathology with a clinically relevant burden of disease was present in 71.1% of the brains, and a selection of premortem neuropsychological and functional scores showed significant correlation with the number of co-pathologies identified in postmortem brains. Conclusions: The VARS cohort, with thorough clinical follow-up, regular blood sampling, 3-Tesla MR, and a high rate of postmortem brain donation, can provide essential multidisciplinary data in the rising age of modifying therapies and biomarkers for Alzheimer’s disease and related dementias.

27 May 2024 in Journal of Comparative Neurology
Verified
Journal Article
Open access
AUAlicia Uceda-Heras
Alicia Uceda-Heras
GAGonzalo Aparicio‐Rodríguez
Gonzalo Aparicio‐Rodríguez
MGMiguel Ángel García‐Cabezas
Miguel Ángel García‐Cabezas
In Alzheimer´s disease (AD), hyperphosphorylated tau spreads along the cerebral cortex in a stereotypical pattern that parallels cognitive deterioration. Tau seems to spread transsynaptically along cortico‐cotical pathways that, according to synaptic tract‐tracing studies in nonhuman primates, have specific laminar patterns related to the cortical type of the connected areas. This relation is described in the Structural Model. In the present article, we study the laminar distribution of hyperphosphorylated tau, labeled with the antibody AT8, along temporal cortical types in postmortem human brains with different AD stages to test the predictions of the Structural Model. Brains from donors without dementia had scant AT8‐immunorreactive (AT8‐ir) neurons in allo‐, meso‐, and isocortical types. In early AD stages, the mesocortical dysgranular type, including part of the transentorhinal cortex, had the highest AT8 immunostaining and AT8‐ir neurons density. In advanced AD stages, AT8 immunostaining increased along the isocortical types until reaching the auditory koniocortex. Regarding laminar patterns, in early AD stages there were more AT8‐ir neurons in supragranular layers in each de novo involved neocortical type; in advanced AD stages, AT8‐ir neurons were equally distributed in supra‐ and infragranular layers. These AT8‐ir laminar patterns are compatible with the predictions of the Structural Model. In summary, we show that hyperphosphorylated tau initially accumulates in allo‐, meso‐, and isocortical types, offer a proof of concept for the validity of the Structural Model to predict synaptic pathway organization in the human cerebral cortex, and highlight the relevance of nonhuman primate tract‐tracing studies to understand human neuropathology.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
AUAlicia Uceda-Heras
Alicia Uceda-Heras
MGMiguel Ángel García-Cabezas
Miguel Ángel García-Cabezas

24 July 2026 in Brain Structure and Function
Verified
Journal Article
Open access
BSBlanca Sánchez-Moreno
Blanca Sánchez-Moreno
AUAlicia Uceda-Heras
Alicia Uceda-Heras
MFMaría de la Fuente-Fernández
María de la Fuente-Fernández
MGMiguel Ángel García-Cabezas
Miguel Ángel García-Cabezas
CCCarmen Cavada
Carmen Cavada
JGJavier Gilabert-Juan
Javier Gilabert-Juan
Foxp2 is a transcription factor essential for the development and function of neural circuits involved in language. Although its expression has been extensively characterized in the cortex and basal ganglia, its organization within the adult thalamus remains poorly understood. In this study, we present a comparative analysis of Foxp2 protein expression across thalamic nuclei in mice, rats, and macaques, with a focus on nuclei associated with higher-order cognitive functions and language-related circuits in humans. We found that Foxp2 is expressed in most thalamic nuclei across species, with a consistent absence in the reticular nucleus and zona incerta. Expression was highest in midline and intralaminar nuclei, whereas the anterior group showed low and variable expression among species. Macaques exhibited broader and, in some nuclei, more intense FoxP2 expression, particularly in associative regions such as the pulvinar and parts of the ventral group, consistent with differences in thalamocortical organization across species. This distribution suggests a conserved role for Foxp2 in shaping thalamic circuits supporting sensorimotor integration, attention, memory, and linguistic processing. Phylogenetic comparisons suggest that enhanced Foxp2 expression in associative thalamic territories in primates may be related to the increased complexity of thalamocortical circuits. These findings provide molecular and anatomical insights into the organization of thalamocortical networks and may offer a framework for understanding their involvement in higher-order cognitive functions and neuropsychiatric disorders.

4 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
SSSevim Kandis Sever
Sevim Kandis Sever
SRSara Ruiz-Cabrera
Sara Ruiz-Cabrera
AUAlicia Uceda-Heras
Alicia Uceda-Heras
DVDavid Vega-Avelaira
David Vega-Avelaira
MGMiguel Ángel García-Cabezas
Miguel Ángel García-Cabezas